Product Document Searching Made Easy by 2D Code! | TCI Materials Science News November 2025 | [TCIPracticalExample] Ullmann-type Coupling Reaction at Room Temperature... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
请选择数量
CAS RN: 202409-33-4 | 产品编码: E1492
Etoricoxib
×
![]()
×
纯度/分析方法: >95.0%(T)(HPLC)
别名：
- 依托考昔
- 5-氯-6′-甲基-3-[4-(甲基磺酰基)苯基]-2,3′-联吡啶
- 5-氯-3-[4-(甲基磺酰基)苯基]-2-(2-甲基-5-吡啶基)吡啶
- 5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine
- 5-Chloro-3-[4-(methylsulfonyl)phenyl]-2-(2-methyl-5-pyridinyl)pyridine
产品文档：
| 产品编码 | E1492 |
纯度/分析方法 
|
>95.0%(T)(HPLC) |
| 分子式/分子量 | C__1__8H__1__5ClN__2O__2S = 358.84 |
| 外观与形状（20°C） | 固体 |
| 储存温度
|
冷藏 (0-10°C) |
| 储存在惰性气体下 | 存放于惰性气体之中 |
| 应避免的情况 | 空气,加热 |
| 包装和容器
|
1G-Glass Bottle with Plastic Insert （查看图片） |
| CAS RN | 202409-33-4 |
| Reaxys-RN | 8073797 |
| MDL编号 | MFCD06797512 |
技术规格
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Purity(Volumetric Analysis) | min. 95.0 % |
| Melting point | 133.0 to 137.0 °C |
| NMR | confirm to structure |
物性（参考值）
| 熔点 | 135 °C |
GHS
相关法规
| RTECS# | DW1762210 |
运输信息
| HS编码* | 2933.39-000 |
应用
Etoricoxib: A Selective Cyclooxygenase-2 (COX-2) Inhibitor
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID), and a selective inhibitor of COX-2 (cyclooxygenase 2) with a higher COX-1 to COX-2 selectivity ratio than the other COX-2-selective inhibitors, such as rofecoxib [R0206], valdecoxib [V0133] or celecoxib [C2816]. The mechanism of action is mainly by inhibition of the enzyme COX in the arachidonic acid metabolism pathway, resulting in reduced prostaglandin synthesis. In theory, a drug that selectively inhibited COX-2 might block inflammation, pain, and fever produced by prostaglandins while reducing the side effects (gastric erosions and ulcers) associated with inhibition of COX-1. (The product is for research purpose only.)
References
- Etoricoxib (a review)
- Selective COX-2 inhibitors: a review of their structure-activity relationships (a review)
- RP-HPLC method for simultaneous estimation of Paracetamol and Etoricoxib from bulk and tablets
- Determination of etoricoxib in human plasma by liquid chromatography-tandem mass spectrometry with electrospray ionisation
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。